GANNEX
Gannex is dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical-stage drug candidates against three different targets — FASN, THR-β, and FXR — and three combination therapies. Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma.
GANNEX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gannexpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Employees Featured
Founder
Official Site Inspections
http://www.gannexpharma.com
- Host name: 47.75.123.183
- IP address: 47.75.123.183
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
Loading ... 